[go: up one dir, main page]

MX2018015187A - Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal. - Google Patents

Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal.

Info

Publication number
MX2018015187A
MX2018015187A MX2018015187A MX2018015187A MX2018015187A MX 2018015187 A MX2018015187 A MX 2018015187A MX 2018015187 A MX2018015187 A MX 2018015187A MX 2018015187 A MX2018015187 A MX 2018015187A MX 2018015187 A MX2018015187 A MX 2018015187A
Authority
MX
Mexico
Prior art keywords
acting
lnnt
preventing
nutritional compositions
rotavirus
Prior art date
Application number
MX2018015187A
Other languages
English (en)
Inventor
Sprenger Norbert
Berger Bernard
Bruessow Harald
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2018015187A publication Critical patent/MX2018015187A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides
    • A23V2250/282—Oligosaccharides, digestible
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición nutricional que comprende al menos un oligosacárido fucosilado y al menos un oligosacárido N-acetilado para prevenir y/o tratar la diarrea no causada por rotavirus en infantes o niños pequeños al actuar sobre la disbiosis de la microbiota antes y/o después de la diarrea no causada por rotavirus. La composición puede ser una fórmula para infantes y, en particular, está destinada a infantes de entre 0 y 12 meses alimentados predominantemente con fórmula para infantes. Promueve una flora intestinal saludable y tiene efectos beneficiosos a corto y largo plazo.
MX2018015187A 2016-08-04 2017-08-04 Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal. MX2018015187A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16182670 2016-08-04
PCT/EP2017/069758 WO2018024870A1 (en) 2016-08-04 2017-08-04 Nutritional compositions with 2fl and lnnt for use in preventing and/or treating non-rotavirus diarrhea by acting on the gut microbiota dysbiosis

Publications (1)

Publication Number Publication Date
MX2018015187A true MX2018015187A (es) 2019-04-24

Family

ID=56609699

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018015187A MX2018015187A (es) 2016-08-04 2017-08-04 Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal.
MX2025003470A MX2025003470A (es) 2016-08-04 2018-12-06 Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2025003470A MX2025003470A (es) 2016-08-04 2018-12-06 Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal

Country Status (7)

Country Link
US (1) US20190160082A1 (es)
EP (1) EP3493817A1 (es)
CN (1) CN109562117A (es)
AU (1) AU2017307455B2 (es)
MX (2) MX2018015187A (es)
PH (1) PH12018502383A1 (es)
WO (1) WO2018024870A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3509438B1 (en) * 2016-09-07 2025-01-22 Société des Produits Nestlé S.A. Nutritional compositions for infants and/or young children comprising oligosaccharides
EP3749328A1 (en) * 2018-02-09 2020-12-16 N.V. Nutricia Fermented formula with non-digestible oligosaccharides
GB2573538B (en) * 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section
EP3820308A1 (en) * 2018-07-12 2021-05-19 N.V. Nutricia Nutritional composition for use in the treatment of diarrhea, its preparation and method of treatment
US20220022515A1 (en) 2019-02-25 2022-01-27 Nutribam Bv Composition, Food Supplement and Method for Supporting and/or Improving Intestinal Health
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
CA3147502A1 (en) * 2019-07-19 2021-01-28 Inbiose N.V. Production of fucosyllactose in host cells
CN113491289A (zh) * 2020-04-03 2021-10-12 内蒙古伊利实业集团股份有限公司 可提升生物体对金黄色葡萄球菌感染的抵御能力的母乳低聚糖
CN113519849B (zh) * 2020-04-14 2023-04-07 内蒙古伊利实业集团股份有限公司 提升肠道对大肠杆菌感染的抵御力的母乳低聚糖及其应用
CN111437282A (zh) * 2020-04-28 2020-07-24 南开大学 2′-岩藻糖基乳糖减少大肠杆菌o157在体内定殖的应用
CN114504107B (zh) * 2020-11-16 2023-08-29 内蒙古伊利实业集团股份有限公司 一种含鼠李糖乳杆菌与母乳低聚糖的组合物及其应用
US20250170163A1 (en) * 2022-02-23 2025-05-29 Societe Des Produits Nestle S.A. Compositions and methods for reducing the occurrence of diarrhea by promoting blautia obeum in the gut microbiota
CN118077909A (zh) * 2022-11-18 2024-05-28 内蒙古伊利实业集团股份有限公司 LNnT作为单一活性组分在制备用于增加肠道中乙酸和/或减少硫化氢的组合物中的应用
CN115868544A (zh) * 2022-11-30 2023-03-31 内蒙古伊利实业集团股份有限公司 含有母乳低聚糖LNnT的无乳糖配方食品及其制备方法与应用
CN117737001B (zh) * 2022-12-27 2024-08-09 菲吉乐科(南京)生物科技有限公司 一种防治犬细菌性腹泻的大肠杆菌噬菌体及其应用
CN115669732B (zh) * 2022-12-29 2023-04-14 内蒙古伊利实业集团股份有限公司 含有母乳低聚糖LNnT的低致敏性婴儿部分水解配方食品
CN121419683A (zh) 2023-04-28 2026-01-27 雀巢产品有限公司 乳糖-n-岩藻五糖和婴儿双歧杆菌保护免受肠道病原体的侵害
DK202430092A1 (en) 2024-02-23 2025-08-29 Dsm Ip Assets Bv Hmo mixture and its use in reducing c. difficile toxins
CN119138609B (zh) * 2024-11-19 2025-02-25 飞鹤(吉林)乳品有限公司 母乳低聚糖改善母婴肠道菌群的用途

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0481038B1 (en) 1990-04-16 2002-10-02 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US5906982A (en) 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US20020019991A1 (en) 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
DE60327211D1 (de) 2002-06-28 2009-05-28 Glykos Finland Oy Therapeutische zusammensetzungen zur verwendung bei der prophylaxe oder behandlung von durchfall
CA2548140A1 (en) * 2003-12-05 2005-06-23 University Of Massachusetts Oligosaccharide compositions and use thereof in the treatment of infection
AU2015218490A1 (en) * 2005-10-21 2015-09-17 N.V. Nutricia Preventing diseases in infants delivered via caesarean section
CN101888793B (zh) * 2007-09-17 2015-01-14 荷兰纽迪希亚公司 具有高能含量的营养配方
MX2010005132A (es) 2007-11-08 2010-06-02 Nestec Sa Uso de oligosacaridos conteniendo n-acetilactosamina para maduración de las respuestas inmunes en neonatos.
CA2725051A1 (en) * 2008-05-27 2009-12-03 Nestec S.A. Probiotics to improve gut microbiota
CA2757169A1 (en) * 2009-04-13 2010-10-21 Children's Hospital Medical Center Milk oligosaccharide compositions and use thereof in treating infection in animals
MX376863B (es) * 2010-12-31 2025-03-07 Abbott Lab Metodos para disminuir la incidencia de la enterocolitis necrotizante en bebes, infantes, o niños al usar los oligosacaridos de leche humana.
JP6129821B2 (ja) 2011-05-13 2017-05-17 グリコシン リミテッド ライアビリティー カンパニー プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
EP2526784A1 (en) 2011-05-24 2012-11-28 Nestec S.A. Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
EP2768311B2 (en) * 2011-10-18 2025-05-28 Société des Produits Nestlé S.A. Composition for use in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
WO2013161820A1 (ja) * 2012-04-23 2013-10-31 国立大学法人京都大学 ビフィズス菌の増殖促進用組成物
US9944965B2 (en) * 2012-12-20 2018-04-17 The Board Of Trustees Of The University Of Illinois Biosynthesis of oligosaccharides
AU2014350157A1 (en) * 2013-11-15 2016-04-14 Nestec S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
EP3068404B1 (en) * 2013-11-15 2021-01-06 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
ES2916813T3 (es) * 2013-11-15 2022-07-06 Nestle Sa Composiciones para uso en la prevención o tratamiento de enterocolitis necrotizante en lactantes y niños pequeños
US10695358B2 (en) * 2013-12-20 2020-06-30 Abbott Laboratories Oral rehydration composition with oligosaccharides
WO2016046294A1 (en) * 2014-09-25 2016-03-31 Nestec S.A. INFANT FORMULA SYSTEM WITH ADAPTIVE LEVELS OF HUMAN MILK OLIGOSACCHARIDES (HMOs)
CN107073021A (zh) * 2014-10-29 2017-08-18 格礼卡姆股份公司 合成组合物以及用于治疗肠易激综合症的方法
EP3212012A1 (en) * 2014-10-31 2017-09-06 Nestec S.A. Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
WO2016091265A1 (en) * 2014-12-08 2016-06-16 Glycom A/S Synthetic composition for treating metabolic disorders
ES2947458T3 (es) * 2015-03-05 2023-08-09 Nestle Sa Composiciones para su uso en la prevención o el tratamiento de infecciones gastrointestinales en lactantes o niños pequeños

Also Published As

Publication number Publication date
RU2019105367A (ru) 2020-09-07
MX2025003470A (es) 2025-05-02
US20190160082A1 (en) 2019-05-30
EP3493817A1 (en) 2019-06-12
CN109562117A (zh) 2019-04-02
WO2018024870A1 (en) 2018-02-08
AU2017307455A1 (en) 2018-11-29
AU2017307455B2 (en) 2023-07-06
PH12018502383A1 (en) 2019-04-08
RU2019105367A3 (es) 2020-09-07

Similar Documents

Publication Publication Date Title
MX2018015187A (es) Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal.
MX2018001117A (es) Composiciones nutricionales con 2fl y lnnt para usar en la induccion de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna.
MX2017010922A (es) Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños.
MX377225B (es) Mezcla sintetica de oligosacaridos de la leche humana (hmo) y composición que la contiene.
EP4494482A3 (en) Compositions for use in improving stool consistency or frequency in infants or young children
PH12018501328A1 (en) Compositions comprising 2fl and lnnt for use in infants or young children to prevent later in life obesity or related comorbidities
MX380540B (es) Composiciones para uso en la prevención o el tratamiento de otitis o bronquitis en infantes o niños pequeños.
PH12018501299A1 (en) Compositions with specific oligosaccharides to prevent later in life obesity or related comorbidities, by increasing colonic scfa production and/or by increasing glp-1 secretion
MX2021006178A (es) Una composicion nutricional que comprende una combinacion de oligosacaridos de la leche humana para mejorar la barrera gastrointestinal.
PH12021551071A1 (en) A nutritional composition comprising 6`sl and lnt in combination to improve the gastrointestinal barrier function
CR10348A (es) Composicion inmunogenica
PH12016500762A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
PH12018501325A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion
MX382069B (es) Composiciones que comprenden 2fl y lnnt para controlar la ingesta de alimento y el crecimiento en infantes o niños pequeños.
PH12018501262A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
PH12019550170A1 (en) Composition comprising oligofructose (of) for use in the improvement of short term memory and other cognitive benefits
PH12018502382A1 (en) Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
MX379151B (es) Composición antirregurgitación que mantiene la motilidad intestinal.
PH12019500092A1 (en) Nutritional compositions for infants and/or young children comprising oligosaccharides
BR112015020465A2 (pt) dispositivo mordedor e consolador e método para formar um dispositivo mordedor e consolador
BR112017007362A2 (pt) composições nutricionais compreendendo sn-1(3)-monoacilgliceróis para uso no tratamento de atrasos de crescimento em bebês ou crianças
TH1801003918A (th) สูตรที่ถูกหมักที่มีโอลิโกแซคคาไรด์ที่ไม่สามารถถูกย่อยได้
TH159428A (th) แลคโตเฟอร์รินสำหรับการป้องกันหรือการรักษาอาการท้องร่วง